Al Mayadeen English

  • Ar
  • Es
  • x
Al Mayadeen English

Slogan

  • News
    • Politics
    • Economy
    • Sports
    • Arts&Culture
    • Health
    • Miscellaneous
    • Technology
    • Environment
  • Articles
    • Opinion
    • Analysis
    • Blog
    • Features
  • Videos
    • NewsFeed
    • Video Features
    • Explainers
    • TV
    • Digital Series
  • Infographs
  • In Pictures
  • • LIVE
News
  • Politics
  • Economy
  • Sports
  • Arts&Culture
  • Health
  • Miscellaneous
  • Technology
  • Environment
Articles
  • Opinion
  • Analysis
  • Blog
  • Features
Videos
  • NewsFeed
  • Video Features
  • Explainers
  • TV
  • Digital Series
Infographs
In Pictures
  • Africa
  • Asia
  • Asia-Pacific
  • Europe
  • Latin America
  • MENA
  • Palestine
  • US & Canada
BREAKING
Netanyahu: If Lebanese Army takes steps to disarm Hezbollah, Israel will engage in reciprocal measures, including phased reduction of Israeli military presence in Lebanon
Al Mayadeen's correspondent: Photojournalist Houssam Al-Masri martyred, reporters Hatem Omar, Mohammad Ashraf Salameh injured in Israeli strike on Nasser Medical Complex.
Israeli media: Intense US efforts are being made to resolve differences, such as the issue of the Israeli presence on Mount Hermon and in southern Syria
Israeli media: The security agreement means amending the disengagement agreement, which will also address the Druze issue
Israeli media: Attempts to reach a security agreement between 'Israel' and Syria were among the topics discussed at the Paris meeting
Israeli media: Sheikh Muwaffaq Tarif rejected a US proposal to join the recent tripartite meeting between Tom Barrack, al-Shaibani, and Dermer
Saba News Agency: Two martyred, five injured in a preliminary toll of the Israeli aggression on the Yemeni Oil Company station on Al-Sitteen Street in Sanaa
Senior Yemeni military source to Al Mayadeen: We observed a state of confusion among the enemy's aircraft squadron after Yemeni air defenses intercepted the attack
Senior Yemeni military source to Al Mayadeen: The Yemeni air defense forces succeeded in neutralizing a squadron of enemy aircraft and prevented airstrikes on some governorates
Senior Yemeni military source to Al Mayadeen: Our air defenses and missile forces forced a formation of enemy aircraft to flee the airspace

Hopes for cancer cure as personal mRNA vaccine for melanoma trialled

  • By Al Mayadeen English
  • Source: News Websites
  • 26 Apr 2024 16:53
  • 1 Shares
3 Min Read

Experts are currently studying new jabs that are custom-built for each patient and instruct their bodies to hunt out cancer cells to prevent the return of the disease.

  • x
  • Hopes for cancer cure as personal mRNA vaccine for melanoma trialled
    A nurse administers the third dose of an experimental breast cancer vaccine to patient Kathleen Jade at the University of Washington Medical Center in Seattle on May 30, 2023 (AP)

Physicians have begun testing the world's first personalized mRNA cancer vaccine for melanoma on a number of patients, with experts hailing its "game-changing" ability to irreversibly cure cancer. 

Melanoma affects around 132,000 individuals worldwide each year and is the leading cause of death from skin cancer. Currently, surgery is the primary treatment, however radiation, medications, and chemotherapy are occasionally employed.

Experts are currently studying new jabs that are custom-built for each patient and instruct their bodies to hunt out cancer cells to prevent the return of the disease.

A phase 2 experiment indicated that the immunizations significantly lowered the probability of cancer recurrence in melanoma patients. A final phase 3 experiment has been initiated, conducted by University College London Hospitals NHS Foundation Trust (UCLH).

MRNA therapy was administered to the first UK patients in February to evaluate the therapy’s safety and effectiveness in treating melanoma, lung cancer, and other solid tumors.

Dr. Heather Shaw, the trial's national coordinating investigator, indicated that the shots have the potential to cure melanoma and are being studied for other malignancies such as lung, bladder, and kidney.

Read more: Dr. Philip Salem: Lebanese architect of the cancer cure, ICTriplex

Shaw called the technology a “really finely honed tool," adding that the patients are "really excited about them."

Related News

Biden diagnosed with 'aggressive' prostate cancer

Senate report reveals Trump slashed cancer research by 31%

The vaccination is an individualized neoantigen treatment. It is meant to activate the immune system so that it can fight back against a patient's particular kind.

The mRNA-4157 (V940) vaccine, targets cancer neoantigens that are expressed by tumors in a specific patient. These are tumor-specific signals that the immune system may identify.

The jab contains code for up to 34 neoantigens and stimulates an anti-tumor immune response based on the specific mutations found in a patient's malignancy.

To personalize it, a tumor sample is extracted during the patient's operation, which is then sequenced using DNA and artificial intelligence. As a consequence, the patient receives a personalized anti-cancer vaccine tailored to his or her tumor.

“It is absolutely custom-built for the patient," Shaw cited. “They may have some shared new antigens, but they’re likely to have their own very individual new antigens that are important to their tumour and so, therefore, it is truly personalized.”

Shaw stated that the ultimate goal is to permanently cure people of cancer

According to Phase 2 data, persons with significant high-risk melanomas who received the jab alongside the immunotherapy Keytruda were nearly half (49%) as likely to die or have their disease return after three years as those who had only Keytruda.

Patients received 1mg of the mRNA vaccine every three weeks for a maximum of nine doses, followed by 200mg of Keytruda every three weeks (maximum of 18 doses) for approximately a year.

The phase 3 worldwide study will now encompass a broader variety of patients and seeks to enroll around 1,100 participants. The UK arm plans to enroll at least 60 to 70 patients across eight centers, including London, Manchester, Edinburgh, and Leeds.

Steve Young, 52, of Stevenage, Hertfordshire, is one of the first patients to participate in the UCLH experiment. "I'm really, really excited," he remarked. "This is my best chance at stopping the cancer in its tracks."

  • Cancer
  • Cancer patients
  • cancer treatment
  • cancer research
  • mRNA
  • melanoma

Most Read

Tom Artiom Alexandrovich, executive director of the defense division of the Israeli National Cyber Directorate, undated (Social media)

Israeli-born US prosecutor drops Israeli officer child sex crime

  • Politics
  • 19 Aug 2025
Displaced Palestinians walk through a makeshift camp along the beach in Gaza City, Sunday, Aug. 10, 2025 (AP)

Hamas, other factions accept Egypt-Qatar ceasefire proposal: Exclusive

  • Politics
  • 18 Aug 2025
Israeli soldiers stand on the top of armoured vehicles parked on an area near the Israeli-Gaza border, as seen from southern Israel, Wednesday, Aug. 20, 2025 (AP)

Palestinian fighters target Israeli soldiers, vehicles in Gaza

  • Politics
  • 21 Aug 2025
Almost instantly after the Helsinki Accords were signed, organisations sprouted to document purported violations, whose findings were fed to overseas embassies for international amplification. (Al Mayadeen English; Illustrated by Zeinab el-Hajj)

How ‘Human Rights’ became a Western weapon

  • Opinion
  • 23 Aug 2025

Coverage

All
The Ummah's Martyrs

Read Next

All
Israeli Prime Minister Benjamin Netanyahu speaks during a press conference at the Prime minister's office in al-Quds, Occupied Palestine, Sunday, Aug. 10, 2025 (AP)
Politics

Netanyahu deliberately derailing truce with Gaza occupation: Hamas

Irish President Michael Higgins arrives to deliver his speech during a 42nd World Food Day celebration at FAO headquarters in Rome, on Oct. 16, 2023. (AP Photo/Alessandra Tarantino)
Politics

Irish president renews call for UN military intervention in Gaza

US Ambassador to Turkey and Special Envoy to Syria Tom Barrack speaks during an interview with The Associated Press at the US Embassy in Aukar, northern suburb of Beirut, Lebanon, Monday, July 21, 2025 (AP)
Politics

US envoy, Netanyahu discuss restraining attacks on Lebanon, withdrawal

Smoke billows following Israeli airstrikes in multiple areas in Sanaa, Yemen, Sunday, Aug. 24, 2025 (AP)
Politics

Ansar Allah vow sustained Gaza support despite Israeli strikes

Al Mayadeen English

Al Mayadeen is an Arab Independent Media Satellite Channel.

All Rights Reserved

  • x
  • Privacy Policy
  • About Us
  • Contact Us
  • Authors
Android
iOS